609 related articles for article (PubMed ID: 16439470)
1. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
2. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
[TBL] [Abstract][Full Text] [Related]
3. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
4. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
5. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.
Yang L; Bataller R; Dulyx J; Coffman TM; Ginès P; Rippe RA; Brenner DA
J Hepatol; 2005 Aug; 43(2):317-23. PubMed ID: 15964094
[TBL] [Abstract][Full Text] [Related]
6. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
[TBL] [Abstract][Full Text] [Related]
7. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
9. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.
Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ
J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation.
Lehnert M; Uehara T; Bradford BU; Lind H; Zhong Z; Brenner DA; Marzi I; Lemasters JJ
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G456-63. PubMed ID: 16614372
[TBL] [Abstract][Full Text] [Related]
12. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
[TBL] [Abstract][Full Text] [Related]
14. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
15. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
Gäbele E; Mühlbauer M; Dorn C; Weiss TS; Froh M; Schnabl B; Wiest R; Schölmerich J; Obermeier F; Hellerbrand C
Biochem Biophys Res Commun; 2008 Nov; 376(2):271-6. PubMed ID: 18760996
[TBL] [Abstract][Full Text] [Related]
16. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.
Iwaisako K; Hatano E; Taura K; Nakajima A; Tada M; Seo S; Tamaki N; Sato F; Ikai I; Uemoto S; Kinoshita M
J Hepatol; 2008 Nov; 49(5):768-78. PubMed ID: 18804890
[TBL] [Abstract][Full Text] [Related]
17. Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse.
Georgiev P; Navarini AA; Eloranta JJ; Lang KS; Kullak-Ublick GA; Nocito A; Dahm F; Jochum W; Graf R; Clavien PA
Gut; 2007 Jan; 56(1):121-8. PubMed ID: 16763052
[TBL] [Abstract][Full Text] [Related]
18. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.
Tacke F; Wüstefeld T; Horn R; Luedde T; Srinivas Rao A; Manns MP; Trautwein C; Brabant G
J Hepatol; 2005 May; 42(5):666-73. PubMed ID: 15826715
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress.
Wagner M; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Gujral JS; Zatloukal K; Denk H; Jaeschke H; Trauner M
Drug Metab Dispos; 2007 Sep; 35(9):1694-9. PubMed ID: 17576807
[TBL] [Abstract][Full Text] [Related]
20. Kupffer cells abrogate cholestatic liver injury in mice.
Gehring S; Dickson EM; San Martin ME; van Rooijen N; Papa EF; Harty MW; Tracy TF; Gregory SH
Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
